PALO ALTO, Calif., Aug. 28, 2019 /PRNewswire/ -- Varian (NYSE:
VAR) has completed the installation of the cyclotron for its
ProBeam® Compact single-room proton therapy system
at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine --
part of the University of Miami Health
System. The cyclotron is a particle accelerator and a
significant piece of the equipment in the ProBeam proton therapy
system. The Center is scheduled to begin patient treatment in the
summer of 2020.
Proton therapy is an advanced form of cancer care. It uses
protons, accelerated to about two-thirds the speed of light, or
more than 100,000 miles per second, to destroy cancer cells, while
minimizing exposure to nearby healthy tissues. The Varian ProBeam
Compact system is the only single room system capable of fully
rotational intensity modulated proton therapy (IMPT). Treatments
can be delivered with an unmatched combination of speed,
flexibility and cost efficiency.
The full-featured ProBeam Compact system includes the cyclotron,
Varian's unique pencil-beam scanning technology for intensity
modulated proton therapy (IMPT), a fully rotational gantry, robotic
patient positioning tools, and a comprehensive suite of motion
management tools. It includes integrated cone beam CT imaging for
positioning the patient based on high quality anatomical images
with excellent soft tissue resolution.
"We selected Varian as our partner because we wanted a company
that understood our mission to reduce the human burden from cancer
through research, education, prevention, and the delivery of
quality patient care," said Dr. Stephen D.
Nimer, director of Sylvester. "We are excited to bring
innovative cancer treatments to patients in our state and region.
They will benefit from having access to therapies that provide
superior dose distribution, spare healthy surrounding tissue and
most importantly, give our patients a better quality of life during
and after treatment. With Varian's help, we are treating cancer
more effectively and efficiently."
"We look forward to continuing this partnership and making this
advanced cancer fighting technology available to more patients in
Florida," said Kolleen Kennedy, president, Proton Solutions and
chief growth officer, Varian. "This advanced treatment technology
has the potential to offer new hope to many cancer patients across
the state and the country."
For more information on ProBeam and its Compact single-room
configuration, visit: www.varian.com/probeamcompact
At Varian, we envision a world without fear of cancer. For more
than 70 years, we have developed, built and delivered innovative
cancer care technologies and solutions for our clinical partners
around the globe to help them treat millions of patients each year.
Taking an Intelligent Cancer Care approach, we are harnessing
advanced technologies like artificial intelligence, machine
learning and data analytics to advance cancer treatment and expand
access to care. Our 9,200 employees across 70 countries keep the
patient and our clinical partners at the center of our thinking as
we power new victories in cancer care. Because, for cancer patients
everywhere, their fight is our fight. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
About Sylvester Comprehensive Cancer Center
Opened in 1973, Sylvester Comprehensive Cancer Center, part of
UHealth – the University of Miami
Health System, is the only NCI-designated Cancer Center in
South Florida and serves as the
hub for cancer-related research, diagnosis, and treatment at
Director, Global Public Relations
+1 (650) 424-5630
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163